According to GlobalData, CARESTART is one of 108 product lines sold in the US covid-19 tests market; these product lines are sold by 60 different manufacturers. The price of the CARESTART device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Access Bio apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Access Bio overview
Access Bio Inc (Access Bio) is a medical device company that research, develops, manufactures and markets in-vitro diagnostics tests, biosensor, and molecular diagnostic products. The company provides in vitro diagnostic technology such as immunochemical, biochemical and molecular products. It utilizes advanced lateral flow technology for the production of its point of care diagnostic products. Access Bio’s products include malaria RDT, G6PD POCT, HPV screening and genotyping test, molecular diagnostics, and others. The company also develops technologies for regents processing. The company operates through its research and development and production facility located in Seoul, Korea. It has presence in Ethiopia, the US and Korea. The company serves non-profit organizations and private companies. Access Bio is headquartered in Somerset, New Jersey,the US.
For a complete picture of CARESTART, COVID-19 Tests pricing in the US, buy the report here.